Moneycontrol PRO
HomeNewsTrendsHealthDrug regulators crack down on companies making substandard medicines

Drug regulators crack down on companies making substandard medicines

Under the drive, licences of 18 firms have either been cancelled or suspended.

March 29, 2023 / 06:21 IST
These 76 firms are spread across 20 states and under phase 1 of the drive, 26 firms have also received show- cause notices. (Representative Image)

In a major crackdown on companies making spurious or substandard medicines in the country, Indian drug regulators have listed 76 firms across 20 states for action, cancelled product permission for three entities and cancelled or suspended manufacturing in 18 firms.

As part of the special drive by the Central Drugs Standard Control Organisation and state drug regulators, 203 firms had been identified and action has been taken against 76 of them which includes issuance of show cause notices to 26 companies.

Top level government sources said on March 28 that the drive, which has followed back to back incidents to some Indian drugmakers supplying adulterated drugs in other countries, will continue even after the current phase is over.

In August last year, Haryana based Maiden Pharmaceuticals had hit headlines internationally after the World Health Organization linked cough syrups supplied by it to the deaths of nearly 70 kids in Gambia.

The WHO had also issued an international drug alert against four of the company's cough syrups.

Few months later, Uzbekistan said that Uttar Pradesh-based Marion Biotech had supplied to the country syrups and mediciens laced with similar contamination.

Also Read | Many commonly used drugs may see a 12% price hike, the highest ever, come April 1

On March 27, the government informed the Lok Sabha that adulterated drugs had been supplied by Hyderabad-based Celon pharma to Yemen.

Himachal Pradesh leads the way

As per the details shared by the Union health ministry, the maximum - 70- number of drug manufacturing units identified for inspection are in Himachal Pradesh, the drug manufacturing hub of India.

Himachal Pradesh is followed by Uttarkhand (45), Madhya Pradesh (23) and Uttar Pradesh (20).

The other states where defaulting drug manufactures are located include West Bengal, Andhra Pradesh, Bihar, Gujarat, Maharashtra, Tamil Nadu, Telangana, and Sikkim among others.

Sumi Sukanya Dutta
Sumi Sukanya Dutta
first published: Mar 28, 2023 05:54 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347